Table 2.
Grade of myodynamia of affected upper limb in each group n (%).
Time | Myodynamia | Control group | Experimental group | Z-valuea | P-value |
---|---|---|---|---|---|
Baseline | Level 0 | 10 (12.50) | 14 (17.50) | −4.494 | 0.621 |
Level 1 | 15 (18.75) | 17 (21.25) | |||
Level 2 | 21 (26.25) | 15 (18.75) | |||
Level 3 | 25 (31.25) | 24 (30.00) | |||
Level 4 | 9 (11.25) | 10 (12.50) | |||
1 month of intervention | Level 0 | 3 (3.75) | 4 (5.00) | −0.163 | 0.870 |
Level 1 | 23 (28.75) | 23 (28.75) | |||
Level 2 | 19 (23.75) | 15 (18.75) | |||
Level 3 | 26 (32.50) | 28 (35.00) | |||
Level 4 | 8 (10.00) | 10 (12.50) | |||
Level 5 | 1 (1.25) | 0 (0.00) | |||
3 months of intervention | Level 0 | 2 (2.50) | 0 (0.00) | −3.563 | < 0.001 |
Level 1 | 16 (20.00) | 8 (10.00) | |||
Level 2 | 29 (36.25) | 22 (27.50) | |||
Level 3 | 25 (31.25) | 23 (28.75) | |||
Level 4 | 7 (8.75) | 26 (32.50) | |||
Level 5 | 1 (1.25) | 1 (1.25) | |||
H-valueb | 0.498 | 20.647 | |||
P-value | 0.780 | < 0.001 |
Mann–Whitney U-test for two independent samples.
Kruskal–Wallis H-test for three independent samples.